http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020031421-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32 |
| filingDate | 2000-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20020031421-A |
| titleOfInvention | Oral dosage forms |
| abstract | The present invention relates to an oral dosage form in which the total release of the active substance is regulated. The active substance is present in the form of two or more different salts, which are present in the dosage form in solid agglomerated state and the active substance is released differently in vitro. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101332744-B1 |
| priorityDate | 1999-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 204.